Sopharma AD (WSE:SPH)
13.45
-1.45 (-9.73%)
Jun 17, 2025, 6:52 PM CET
Sopharma AD Revenue
Sopharma AD had revenue of 644.07M BGN in the quarter ending March 31, 2025, with 25.43% growth. This brings the company's revenue in the last twelve months to 2.27B, up 17.44% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.
Revenue (ttm)
2.27B BGN
Revenue Growth
+17.44%
P/S Ratio
0.50
Revenue / Employee
405.44K BGN
Employees
5,599
Market Cap
2.42B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Synektik Spólka Akcyjna | 593.62M |
Voxel | 556.98M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Centrum Medyczne ENEL-MED | 762.83M |
Selvita | 359.79M |
EMC Instytut Medyczny | 836.81M |